NUVB position history
The shares of Nuvation Bio (NUVB) that DME Capital Management reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2024 Q1: 34,995 shares, $127K, <0.01% of portfolio
- 2024 Q2: 34,995 shares, $102K, <0.01% of portfolio
- 2024 Q3: 34,995 shares, $80K, <0.01% of portfolio
- 2024 Q4: 34,995 shares, $93K, <0.01% of portfolio
- 2025 Q1: 34,995 shares, $62K, <0.01% of portfolio
- 2025 Q2: 34,995 shares, $68K, <0.01% of portfolio
- 2025 Q3: 34,995 shares, $129K, <0.01% of portfolio
- 2025 Q4: 34,995 shares, $314K, 0.01% of portfolio
- 2026 Q1: 34,995 shares, $150K, <0.01% of portfolio
- 2026 Q2: 34,995 shares, $199K, <0.01% of portfolio
- 2026 Q3: 34,995 shares, $196K, <0.01% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|